Protagenic Therapeutics, Inc. (PTIX)
0.4205
-0.05
(-10.94%)
USD |
OTCM |
Feb 20, 16:00
Protagenic Therapeutics EPS Diluted (Quarterly) : -0.4702 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biogen, Inc. | -0.3333 |
| Vanda Pharmaceuticals, Inc. | -2.389 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.8695M |
| Total Expenses (Quarterly) | 0.8695M |
| Enterprise Value | 1.523M |
| Earnings Yield | -1.89K% |
| Normalized Earnings Yield | -1822.88 |